| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Jul 18, 2025 | Jul 22, 2025 | Taub Rebecca Dir | Sell | $350.01 | $350,005 | -0.09% |
| Jul 18, 2025 | Jul 22, 2025 | Friedman Paul A Dir | Sell | $350.03 | $490,044 | -0.17% |
| Jul 16, 2025 | Jul 18, 2025 | Friedman Paul A Dir | Sell | $353.19 | $10M | -3.31% |
| Jul 16, 2025 | Jul 18, 2025 | Taub Rebecca Dir | Sell | $353.19 | $10M | -2.54% |
| Mar 12, 2025 | Mar 14, 2025 | Craves Fred B Dir | Sell | $328.54 | $5M | -3.88% |
| Mar 10, 2025 | Mar 12, 2025 | Dier Mardi SVP CFO | Sell | $323.04 | $83,344 | -2.41% |
| Mar 05, 2025 | Mar 07, 2025 | Waltermire Robert E. SVP Chief Pharma Dev. | Sell | $341.32 | $5M | -70.91% |
| Mar 03, 2025 | Mar 05, 2025 | Kelley Shannon T GC | Sell | $335 | $139,025 | -5.39% |
| Mar 03, 2025 | Mar 05, 2025 | Dier Mardi SVP CFO | Sell | $324.96 | $637,248 | -22.10% |
| Mar 03, 2025 | Mar 05, 2025 | Huntsman Carole Chief Commercial Officer | Sell | $325.98 | $597,840 | -17.57% |
| Feb 28, 2025 | Mar 05, 2025 | Waltermire Robert E. SVP Chief Pharma Dev. | Sell | $341.07 | $418,488 | -24.76% |
| Feb 27, 2025 | Feb 28, 2025 | Daly James M Dir | Sell | $347.46 | $5M | -89.00% |
| Feb 27, 2025 | Feb 28, 2025 | Bate Kenneth Dir | Sell | $356.44 | $7M | -91.27% |
| Jan 24, 2025 | Jan 27, 2025 | Huntsman Carole Chief Commercial Officer | Sell | $335.24 | $116,328 | -3.22% |
| Jan 24, 2025 | Jan 27, 2025 | Sibold William John Pres CEO | Sell | $335.24 | $531,020 | -2.83% |
| Jan 24, 2025 | Jan 27, 2025 | Taub Rebecca Pres R D CMO | Sell | $335.24 | $217,236 | -0.06% |
| Jan 24, 2025 | Jan 27, 2025 | Waltermire Robert E. SVP Chief Pharma Dev. | Sell | $335.24 | $34,530 | -2.04% |
| Jan 17, 2025 | Jan 18, 2025 | Kelley Shannon T GC | Sell | $273.41 | $75,735 | -3.47% |
| Jan 17, 2025 | Jan 18, 2025 | Waltermire Robert E. SVP Chief Pharma Dev. | Sell | $273.41 | $120,847 | -8.04% |
| Jan 17, 2025 | Jan 18, 2025 | Taub Rebecca Pres R D CMO | Sell | $273.41 | $461,789 | -0.15% |
| Dec 03, 2024 | Dec 05, 2024 | Craves Fred B Dir | Sell | $315.31 | $1M | -0.93% |
| Nov 25, 2024 | Nov 27, 2024 | Craves Fred B Dir | Sell | $350.3 | $1M | -0.87% |
| Nov 21, 2024 | Nov 22, 2024 | Huntsman Carole Chief Commercial Officer | Sell | $316.92 | $218,041 | -6.00% |
| Nov 07, 2024 | Nov 08, 2024 | Levy Richard S Dir | Sell | $350 | $2M | -31.23% |
| Nov 01, 2024 | Nov 06, 2024 | Levy Richard S Dir | Sell | $300.94 | $2M | -31.23% |
| Sep 09, 2024 | Sep 12, 2024 | Sibold William John Pres CEO | Sell | $243.83 | $2M | -10.22% |
| Jun 14, 2024 | Jun 19, 2024 | Waltermire Robert E. SVP Chief Pharma Dev. | Sell | $280 | $532,000 | -25.68% |
| Jun 12, 2024 | Jun 15, 2024 | Waltermire Robert E. SVP Chief Pharma Dev. | Sell | $285 | $570,000 | -26.67% |
| May 21, 2024 | May 24, 2024 | Waltermire Robert E. SVP Chief Pharma Dev. | Sell | $231.34 | $239,668 | -15.85% |
| May 14, 2024 | May 17, 2024 | Craves Fred B Dir | Sell | $212.88 | $5M | -4.39% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.